·维勒布兰德因子的个体内变异性以及需要重复测试的需要
Malene Helligsø Kirkeby1, Johanne Andersen Højbjerg1,2, Anders Mønsted Abildgaard1,2
1Department of Clinical Biochemistry, Aarhus University Hospital, Denmark.
Research and practice in thrombosis and haemostasis
|June 18, 2025
概括
·维勒布兰德因子 (VWF) 水平的个体内变化使诊断复杂化. 在VWF水平接近诊断截止点时,重复测试对于准确的维尔布兰德病 (VWD) 诊断至关重要.
科学领域:
- 血液学 血液学 血液学
- 临床化学 临床化学
- 诊断医学 诊断医学
背景情况:
- 诊断·威尔布兰德病 (VWD) 是具有挑战性的,因为在·威尔布兰德因子 (VWF) 水平显著的个体内变化.
- 目前对VWD的诊断指南依赖于VWF抗原 (VWF:Ag) 或活动水平低于特定值 (0.30或0.50 × 103 IU/L).
- 对于患有接近这些诊断截止点的VWF水平的患者需要重复测试的必要性,没有确立的共识.
研究的目的:
- 调查VWF抗原 (VWF:Ag),VWF血小板结合活性 (VWF:GPIbR) 和VWF原结合活性 (VWF:CB) 的个体内变异程度.
- 根据观察到的VWF变异,使用单个血液样本确定可靠的切断值,以排除VWD.
- 通过评估VWF变异性的影响,为VWD的诊断策略提供信息.
主要方法:
- 一项横截面研究分析了VWF:Ag,VWF:GPIbR和VWF:CB.CB的例行患者数据.
- 数据是从2013年1月到2024年1月从奥胡斯大学医院临床化学系提取的.
- 计算的非分析变化系数 (CVnonanalytical) 用于量化变化和估计方法特定的单个样本截止值.
主要成果:
- 对VWF:Ag,VWF:GPIbR和VWF:CB的非分析CV分别为22.03%,24.10%和24.07%,表明了实质性的个体内变化.
- 基于性别,年龄或VWF水平的亚组之间没有观察到CVnonanalytical的显著差异.
- 用单个样本排除VWD的方法特定的截止值被确定为0.67 × 103 IU/L (VWF:Ag),0.66 × 103 IU/L (VWF:GPIbR) 和0.88 × 103 IU/L (VWF:CB).
结论:
- 在接受VWF测试的患者中,VWF水平存在相当大的个体内变化.
- 这些发现强调了在水平接近下诊断范围时重复VWF测试的关键重要性.
- 这种方法是必要的,以防止虚假排除真正的·维莱布兰德病诊断.
相关概念视频
Variability: Analysis
192
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
The range is a simple measure of variability, indicating the difference between the highest and...
192
Blood Typing
1.6K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
1.6K
Blood Transfusion and Agglutination
11.3K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.3K


